Table 1B.
Clinicopathologic data of the ovarian cohort patients (N=14)
| Sex | |
| Female | 14 (100%) |
| Age (Mean/Range) | 45.29 (16-78) |
| Diagnosis Age | |
| <35 | 3 (21.43%) |
| 35-44 | 2 (14.29%) |
| 45-54 | 6 (42.86%) |
| 55-64 | 2 (14.29%) |
| ≥65 | 1 (7.14%) |
| Personal cancers | |
| Ovarian Cancer | 14 (100%) |
| Menopause | |
| Yes | 9 (64.29%) |
| Family History (1st or 2nd degree) | |
| Breast Cancer | 2 (14.29%) |
| Ovarian Cancer | 0 (0%) |
| BRCA Related Cancer (other than Breast & Ovarian) | 2 (14.29%) |
| Histology of Ovarian tumors | |
| Serous | 5 (35.71%) |
| Mucinous | 2 (14.29%) |
| Endometrioid | 6 (42.86%) |
| Metastatic adenocarcinoma | 1 (7.14%) |
| FIGO Stage | |
| I | 4 (30.77%) |
| II | 1 (7.69%) |
| III | 7 (53.85%) |
| IV | 1 (7.69%) |
| Not stated | 1 |
| Grade | |
| 1 | 1 (7.69%) |
| 2 | 4 (30.77%) |
| 3 | 8 (61.54%) |
| Not stated | 1 |